# Open Label Use Of RiaStap During Aortic Reconstruction

> **NCT01300286** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 23 (actual)

## Conditions studied

- Coagulopathic Bleeding

## Interventions

- **DRUG:** RiaSTAP

## Key facts

- **NCT ID:** NCT01300286
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2014-12-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01300286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01300286, "Open Label Use Of RiaStap During Aortic Reconstruction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01300286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*